What is CMC?
Chemistry, Manufacturing, and Controls. The US regulatory label for everything about a drug substance and drug product — composition, manufacturing, specifications, stability, container / closure, impurity profile. ICH and EMA call the same body of work "Quality." The content is identical; only the label differs.
Short answer. CMC (US convention) = Quality (ICH/EMA convention). Both terms describe the content that lives in Module 3 of the CTD. The ICH Q-series (Q1 through Q13) is the authoritative reference set for how that content is structured and defended.
What CMC content includes
- Drug substance (3.2.S): general information, manufacture, characterization, control of drug substance, reference standards, container/closure, stability.
- Drug product (3.2.P): description and composition, pharmaceutical development, manufacture, control of excipients, control of drug product, reference standards, container/closure, stability.
- Appendices (3.2.A): facilities and equipment, adventitious agents safety evaluation, novel excipients.
- Regional information (3.2.R): region-specific supplementary content (e.g., executed batch records for US, process validation scheme).
The ICH Q-series in one line each
- Q1A(R2) - Q1F, Q1E. Stability testing of new drug substances and products; bracketing and matrixing (Q1D); evaluation of stability data (Q1E).
- Q2(R2) / Q14 (in force 2025). Analytical method validation and development.
- Q3A(R2), Q3B(R2), Q3C(R9), Q3D(R2). Impurities in new drug substances, impurities in new drug products, residual solvents, elemental impurities.
- Q5A(R2), Q5B, Q5C, Q5D, Q5E. Viral safety, analytical comparability, stability of biotech products, cell substrate, comparability of biotech products subject to manufacturing changes.
- Q6A, Q6B. Specifications for new drug substances and products (small molecule, biotech).
- Q7. Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
- Q8(R2). Pharmaceutical Development.
- Q9(R1) (2023). Quality Risk Management.
- Q10. Pharmaceutical Quality System (PQS).
- Q11. Development and Manufacture of Drug Substances (chemical entities and biotech/biological).
- Q12. Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.
- Q13 (2023). Continuous Manufacturing of Drug Substances and Drug Products.
CMC vs Quality: the naming convention
Historically US FDA regulatory affairs used "CMC" as the umbrella term. ICH — formed from FDA, EMA, MHLW/PMDA, plus Health Canada and Swissmedic as observers — adopted "Quality" as the neutral label for Module 3. EMA follows ICH terminology. In practice, the CMC Lead at a US sponsor and the Quality Affairs Lead at an EMA sponsor are doing the same job with different titles.
Day-to-day responsibilities of a CMC team
- Author and review Module 3 content before submission.
- Respond to agency information requests (FDA complete response letters, EMA day 120 and day 180 questions).
- Manage post-approval changes (CBE-30, PAS, Type IA/IB/II variations, Notifiable Changes).
- Run stability programs per ICH Q1 and update shelf-life on the label as data accumulates.
- Qualify analytical methods per ICH Q2(R2) / Q14.
- Investigate out-of-specification results per FDA OOS guidance.
- Coordinate tech transfers under WHO TRS 961 Annex 7 framework.
Related glossary entries
Frequently asked questions
What does CMC stand for?
Chemistry, Manufacturing, and Controls. Everything about the drug substance and drug product — composition, manufacturing process, specifications, stability, container / closure, impurity profile. In a CTD submission, CMC content lives in Module 3.
Is CMC the same as Quality?
Functionally yes. "CMC" is US convention; "Quality" is ICH and EMA convention. Same content, different label. Module 3 of the CTD carries it regardless.
Which ICH guidelines cover CMC?
The ICH Q-series: Q1 (stability), Q2 / Q14 (method validation), Q3 (impurities), Q5 (biotech), Q6 (specifications), Q7 (API GMP), Q8 (pharmaceutical development), Q9 (risk), Q10 (PQS), Q11 (drug substance), Q12 (lifecycle), Q13 (continuous manufacturing).
What does a CMC team actually do day to day?
Author and review Module 3 content, respond to agency questions, manage post-approval changes, run stability programs, qualify analytical methods, investigate OOS results, and coordinate tech transfers.